Published in Medical Patent Law Weekly, March 26th, 2008
The Greece Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Greece's pharmaceuticals and healthcare industry.
The Greek pharmaceutical market remains one of the least-developed of the European Union (EU)-15 markets. The generics segment accounts for only around 10% of the total market by value, although as the government realises the amount of potential savings made from higher usage of copy drugs, their share will rise over the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.